Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition.

Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis, which kills 1.8 million annually. Mtb RNA polymerase (RNAP) is the target of the first-line antituberculosis drug rifampin (Rif). We report crystal structures of Mtb RNAP, alone and in complex with Rif, at 3.8-4.4 Å resolution. The results identify an Mtb-specific structural module of Mtb RNAP and establish that Rif functions by a steric-occlusion mechanism that prevents extension of RNA. We also report non-Rif-related compounds-Nα-aroyl-N-aryl-phenylalaninamides (AAPs)-that potently and selectively inhibit Mtb RNAP and Mtb growth, and we report crystal structures of Mtb RNAP in complex with AAPs. AAPs bind to a different site on Mtb RNAP than Rif, exhibit no cross-resistance with Rif, function additively when co-administered with Rif, and suppress resistance emergence when co-administered with Rif.

[1]  D. Hinton,et al.  Domain 1.1 of the sigma(70) subunit of Escherichia coli RNA polymerase modulates the formation of stable polymerase/promoter complexes. , 2001, Journal of molecular biology.

[2]  Analysis of the Luria-Delbrück distribution using discrete convolution powers , 1992 .

[3]  S. Sarkar,et al.  On fluctuation analysis: a new, simple and efficient method for computing the expected number of mutants , 2004, Genetica.

[4]  R. Ebright,et al.  GE23077 binds to the RNA polymerase ‘i’ and ‘i+1’ sites and prevents the binding of initiating nucleotides , 2014, eLife.

[5]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[6]  R. Ebright,et al.  Fluorescence anisotropy: rapid, quantitative assay for protein-DNA and protein-protein interaction. , 1996, Methods in enzymology.

[7]  Arkady Mustaev,et al.  Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase , 2001, Cell.

[8]  Jookyung J Lee,et al.  Bacterial RNA Polymerase-DNA Interaction—The Driving Force of Gene Expression and the Target for Drug Action , 2016, Front. Mol. Biosci..

[9]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[10]  R. Young,et al.  Prokaryotic and eukaryotic RNA polymerases have homologous core subunits. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Jean-François Jacques,et al.  A recombinant Mycobacterium tuberculosis in vitro transcription system. , 2006, FEMS microbiology letters.

[12]  R. Landick,et al.  The bridge helix coordinates movements of modules in RNA polymerase , 2010, BMC Biology.

[13]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[14]  S. Darst,et al.  CBR antimicrobials inhibit RNA polymerase via at least two bridge-helix cap-mediated effects on nucleotide addition , 2015, Proceedings of the National Academy of Sciences.

[15]  R. Ebright,et al.  Structural Basis of Transcription Initiation , 2012, Science.

[16]  Chang-Xing Ma,et al.  Fluctuation AnaLysis CalculatOR: a web tool for the determination of mutation rate using Luria-Delbrück fluctuation analysis , 2009, Bioinform..

[17]  F. M. Stewart,et al.  Fluctuation analysis: the probability distribution of the number of mutants under different conditions. , 1990, Genetics.

[18]  Naohiro Matsugaki,et al.  Allosteric Modulation of the RNA Polymerase Catalytic Reaction Is an Essential Component of Transcription Control by Rifamycins , 2005, Cell.

[19]  R. Ebright,et al.  Transcription inhibition by the depsipeptide antibiotic salinamide A , 2014, eLife.

[20]  W. Lane,et al.  Molecular evolution of multisubunit RNA polymerases: sequence analysis. , 2010, Journal of molecular biology.

[21]  K. Murakami.  Structural Biology of Bacterial RNA Polymerase , 2015, Biomolecules.

[22]  Jennifer L. Knight,et al.  Structural Organization of Bacterial RNA Polymerase Holoenzyme and the RNA Polymerase-Promoter Open Complex , 2002, Cell.

[23]  R. Ebright,et al.  Structural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR Pyrazoles. , 2015, Structure.

[24]  Sahotra Sarkar,et al.  Analysis of the Luria–Delbrück distribution using discrete convolution powers , 1992, Journal of Applied Probability.

[25]  M. Glickman,et al.  Structure and function of the mycobacterial transcription initiation complex with the essential regulator RbpA , 2017, eLife.

[26]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[27]  R. Ebright,et al.  Rifamycins do not function by allosteric modulation of binding of Mg2+ to the RNA polymerase active center , 2008, Proceedings of the National Academy of Sciences.

[28]  Clement S. Chu,et al.  A New Class of Bacterial RNA Polymerase Inhibitor Affects Nucleotide Addition , 2003, Science.

[29]  C. S. Millard,et al.  Production of selenomethionine-labeled proteins in two-liter plastic bottles for structure determination , 2004, Journal of Structural and Functional Genomics.

[30]  D S Burgess,et al.  Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test , 1996, Antimicrobial agents and chemotherapy.

[31]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[32]  K. Severinov,et al.  Topology of the RNA polymerase active center probed by chimeric rifampicin-nucleotide compounds. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Greenleaf,et al.  Analysis of the gene encoding the largest subunit of RNA polymerase II in Drosophila , 2004, Molecular and General Genetics MGG.

[34]  R. Ebright,et al.  Frequency, Spectrum, and Nonzero Fitness Costs of Resistance to Myxopyronin in Staphylococcus aureus , 2012, Antimicrobial Agents and Chemotherapy.

[35]  R. Weinzierl.  The nucleotide addition cycle of RNA polymerase is controlled by two molecular hinges in the Bridge Helix domain , 2010, BMC Biology.

[36]  R. Ebright,et al.  New target for inhibition of bacterial RNA polymerase: 'switch region'. , 2011, Current opinion in microbiology.

[37]  S. Darst,et al.  Mycobacterial RNA polymerase forms unstable open promoter complexes that are stabilized by CarD , 2014, Nucleic acids research.

[38]  L. Collins,et al.  Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium , 1997, Antimicrobial agents and chemotherapy.

[39]  K. Murakami,et al.  X-ray crystal structures of the Escherichia coli RNA polymerase in complex with benzoxazinorifamycins. , 2013, Journal of medicinal chemistry.

[40]  T. Walsh,et al.  Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro-In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus , 2009, Antimicrobial Agents and Chemotherapy.

[41]  J. Mukhopadhyay,et al.  Optimization of recombinant Mycobacterium tuberculosis RNA polymerase expression and purification. , 2014, Tuberculosis.

[42]  K. Kerrebijn,et al.  Antibiotic interaction: Interpretation of fractional inhibitory and fractional bactericidal concentration indices , 1987, European Journal of Clinical Microbiology.

[43]  H. Showalter,et al.  Rifamycins--obstacles and opportunities. , 2010, Tuberculosis.

[44]  R. Ebright,et al.  Structural basis of Mycobacterium tuberculosis transcription and transcription inhibition , 2017, bioRxiv.

[45]  Joe A. FRALICKl,et al.  Additive effect of tolC and rfa mutations on the hydrophobic barrier of the outer membrane of Escherichia coli K-12 , 1994, Journal of bacteriology.

[46]  S. Darst,et al.  Phage T7 Gp2 inhibition of Escherichia coli RNA polymerase involves misappropriation of σ70 domain 1.1 , 2013, Proceedings of the National Academy of Sciences.

[47]  D. Rothstein.  Rifamycins, Alone and in Combination. , 2016, Cold Spring Harbor perspectives in medicine.

[48]  C. Sassetti,et al.  Mycobacterial recombineering. , 2015, Methods in molecular biology.